Epidermal fatty acid binding protein as a diagnostic marker in Sjogren Syndrome

Epidermal fatty acid binding protein as a diagnostic marker in Sjogren Syndrome - E-FABP and SS

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023410

Enrollment

Registered

2016-07-30

Start date

2016-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sjogren Syndrome

Interventions

Observation period:1 year Visit number: Once

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Sjogren syndrome

Exclusion criteria

Exclusion criteria: Systemic disease other than SS

Design outcomes

Primary

Measure	Time frame
E-FABP	—

Secondary

Measure	Time frame
Inflammatory cytokines	—

Countries

Japan

Contacts

Public ContactDogru Murat

Tokyo Dental College Ophthalmology

muratodooru2005@yahoo.co.jp047-322-0151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026